ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	14/95	120/7206	3.85307678101e-10
ko04380	Osteoclast differentiation	11/95	134/7206	1.2585748945e-06
ko01522	Endocrine resistance	10/95	124/7206	4.64827960922e-06
ko04672	Intestinal immune network for IgA production	6/95	37/7206	7.48778353216e-06
ko04933	AGE-RAGE signaling pathway in diabetic complications	9/95	135/7206	6.54209137649e-05
ko04610	Complement and coagulation cascades	7/95	79/7206	7.41065562469e-05
ko05161	Hepatitis B	10/95	173/7206	8.5061312831e-05
ko04060	Cytokine-cytokine receptor interaction	10/95	191/7206	0.000193173205015
ko04621	NOD-like receptor signaling pathway	9/95	157/7206	0.000208641064419
ko04620	Toll-like receptor signaling pathway	7/95	100/7206	0.000326910615831
ko05418	Fluid shear stress and atherosclerosis	9/95	173/7206	0.000429697205879
ko05167	Kaposi's sarcoma-associated herpesvirus infection	9/95	191/7206	0.0008798325885
ko04660	T cell receptor signaling pathway	7/95	124/7206	0.00118989683626
ko05145	Toxoplasmosis	7/95	126/7206	0.00130647899226
ko05166	HTLV-I infection	11/95	292/7206	0.00150506578987
ko04658	Th1 and Th2 cell differentiation	6/95	96/7206	0.00160001599342
ko05160	Hepatitis C	7/95	153/7206	0.0039332078286
ko05162	Measles	6/95	120/7206	0.00489911228478
ko05200	Pathways in cancer	14/95	492/7206	0.00598802097226
ko05321	Inflammatory bowel disease (IBD)	4/95	56/7206	0.0061689952845
ko05164	Influenza A	7/95	167/7206	0.00633154838091
ko05120	Epithelial cell signaling in Helicobacter pylori infection	5/95	92/7206	0.00714468888113
ko04064	NF-kappa B signaling pathway	5/95	96/7206	0.00852312155152
ko04330	Notch signaling pathway	4/95	62/7206	0.00882553225843
ko05205	Proteoglycans in cancer	9/95	271/7206	0.00916467274413
ko04010	MAPK signaling pathway	10/95	321/7206	0.0093790698078
ko04210	Apoptosis	7/95	180/7206	0.00941052314551
ko05152	Tuberculosis	7/95	187/7206	0.011464780194
ko04670	Leukocyte transendothelial migration	6/95	151/7206	0.0144404768473
ko05215	Prostate cancer	5/95	111/7206	0.0153267719996
ko04623	Cytosolic DNA-sensing pathway	3/95	41/7206	0.0164807138403
ko05144	Malaria	3/95	45/7206	0.0211279084004
ko05230	Central carbon metabolism in cancer	4/95	81/7206	0.0217999044897
ko05212	Pancreatic cancer	4/95	83/7206	0.0236072341108
ko04215	Apoptosis - multiple species	3/95	47/7206	0.0236937572443
ko05219	Bladder cancer	3/95	48/7206	0.0250373249376
ko05220	Chronic myeloid leukemia	4/95	85/7206	0.0255032652288
ko05224	Breast cancer	6/95	174/7206	0.0269757406632
ko04657	IL-17 signaling pathway	4/95	87/7206	0.0274888313746
ko05142	Chagas disease (American trypanosomiasis)	5/95	130/7206	0.028205569806
ko05206	MicroRNAs in cancer	6/95	177/7206	0.0290171406501
ko04915	Estrogen signaling pathway	5/95	131/7206	0.0290284179087
ko05203	Viral carcinogenesis	8/95	277/7206	0.0292231410833
ko05323	Rheumatoid arthritis	4/95	89/7206	0.0295646524055
ko04630	Jak-STAT signaling pathway	5/95	132/7206	0.0298663854817
ko05168	Herpes simplex infection	6/95	182/7206	0.0326420648652
ko04932	Non-alcoholic fatty liver disease (NAFLD)	6/95	182/7206	0.0326420648652
ko04931	Insulin resistance	5/95	137/7206	0.0342854583047
ko05211	Renal cell carcinoma	4/95	96/7206	0.0375485641084
ko05330	Allograft rejection	2/95	24/7206	0.039329263693
ko05132	Salmonella infection	4/95	98/7206	0.0400364733944
ko05100	Bacterial invasion of epithelial cells	4/95	99/7206	0.041315020675
ko04080	Neuroactive ligand-receptor interaction	1/95	423/7206	0.044281774833
ko04062	Chemokine signaling pathway	6/95	201/7206	0.0490595214293
ko05221	Acute myeloid leukemia	3/95	63/7206	0.0499739788445